Study of How Different Depths of Endoscopic Submucosal Dissection Affect Scar Size and Healing in Early Gastric Cancer Treatment

What this Trial Is About

Researchers are studying early gastric cancer to understand how the depth of endoscopic submucosal dissection ESD affects scar formation and patient outcomes. This clinical trial aims to provide clear evidence about the impact of different peeling depths during ESD on scar size, gastric function, and prognosis. The goal is to improve treatment guidelines and techniques for early gastric cancer. Participants will undergo ESD treatment with one of two approaches either including the deepest third of the submucosa layer SM3 or not including it. Both groups receive the procedure following standard ESD methods. The study compares these two depths to evaluate how they affect healing and scar formation over time. During the trial, researchers will monitor participants for one year, measuring the scar area and observing gastric function to assess healing. Follow-up visits will include examinations and assessments to track outcomes and overall health. This trial is randomized and double-blind, ensuring careful evaluation of the two ESD techniques over the study period.

The Relationship Between Scar Formation and ESD Depth in Therapy for Gastric Carcinoma